Clinical Scorecard: UCI Health at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

At a Glance

Key Highlights

• Showcasing advancements in cancer care at ASCO 2026
• Focus on innovative therapies and clinical trials
• Discussion on daraxonrasib data for metastatic pancreatic adenocarcinoma
• Presentations on various cancer treatments and studies
• Networking opportunities at Connect & Cure event

Guideline-Based Recommendations

Diagnosis

• Utilize multidisciplinary expertise for accurate cancer diagnosis

Management

• Implement precision medicine approaches in treatment plans

Monitoring & Follow-up

• Regular follow-ups and assessments in clinical trials

Risks

• Consider potential side effects of new therapies

Patient & Prescribing Data

Patients with recurrent or metastatic cancers

Emerging therapies include RAS-directed treatments and antibody-drug conjugates

Clinical Best Practices

• Engage in translational research to enhance treatment options
• Promote access to clinical trials for eligible patients
• Encourage collaboration among oncology specialists

Related Resources & Content

• UCI Health